SCHEMBL18846992

SCHEMBL18846992

c1ccc(-n2c3ccccc3c3ccc4c(-c5cccc(-c6cc(-n7c8ccccc8c8ccccc87)cc(-n7c8ccccc8c8ccccc87)c6)c5)nc5ccccc5c4c32)cc1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ KMT2A Q03164 4/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ GAA P10253 1/20 0.35
▸ IL1R1 P14778 1/20 0.33
▸ ADORA2A P29274 3/20 0.33
▸ HTT P42858 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ POLB P06746 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ RXFP1 Q9HBX9 2/20 0.32
▸ PDE10A Q9Y233 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ TP53 P04637 2/20 0.32
▸ RAD51 Q06609 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18847141 0.95 L3MBTL1 (0.42) L3MBTL1KDM4EATMKMT2AMEN1
SCHEMBL18847291 0.94 GAA (0.38) L3MBTL1KDM4EATMKMT2AMEN1
SCHEMBL18846926 0.91 L3MBTL1 (0.40) L3MBTL1KDM4EATMKMT2AMEN1
SCHEMBL18846523 0.91 L3MBTL1 (0.40) L3MBTL1KDM4EATMKMT2AMEN1
SCHEMBL18846881 0.91 L3MBTL1 (0.42) L3MBTL1KDM4EATMKMT2AMEN1
SCHEMBL18847731 0.91 KDM4E (0.41) L3MBTL1KDM4EATMKMT2AMEN1
SCHEMBL18846995 0.91 L3MBTL1 (0.41) L3MBTL1KDM4EATMKMT2AMEN1
SCHEMBL18847135 0.90 L3MBTL1 (0.37) L3MBTL1KDM4EATMKMT2AMEN1
SCHEMBL18847217 0.90 KDM4E (0.38) L3MBTL1KDM4EATMKMT2AMEN1
SCHEMBL18846923 0.90 L3MBTL1 (0.38) L3MBTL1KDM4EATMKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10446765-B2 Heterocyclic compound and organic light emitting element using same HEESUNG MATERIAL LTD. (KR) 2019-10-15 — — US disclosed
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-11 — — US disclosed
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME CRY1, CRY2, PER2 L3MBTL1 995/4885KDM4E 1869/4885ATM 3417/4885
US-10446765-B2 Heterocyclic compound and organic light emitting element using same CRY1, CRY2, PER2 L3MBTL1 995/4885KDM4E 1869/4885ATM 3417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback